Neuca

Neuca Operating Expenses

The Total Operating Expenses of Neuca (NEU.WA) as of Oct 21, 2026 is 459.99 M PLN. In the previous year, Total Operating Expenses was 387.40 M PLN — a change of 18.74% (higher).

Operating Expenses

459.99 MPLN

YoY

18.74%

Last updated:

Total Operating Expenses of Neuca is 2025 459.99 M PLN. Total Operating Expenses of Neuca was 2024 387.40 M PLN. It decreases by 18.74% higher compared to the previous year.

The Neuca Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
182.96 M PLN
Jan 1, 2019
182.31 M PLN
Jan 1, 2020
205.56 M PLN
Jan 1, 2021
242.50 M PLN
Jan 1, 2022
368.51 M PLN
Jan 1, 2023
356.53 M PLN
Jan 1, 2024
387.40 M PLN
Jan 1, 2025
459.99 M PLN
The Neuca Operating Expenses history
YEAROperating ExpensesYoY
459.99 MPLN+18.74%
387.40 MPLN+8.66%
356.53 MPLN-3.25%
368.51 MPLN+51.97%
242.50 MPLN+17.97%
205.56 MPLN+12.75%
182.31 MPLN-0.36%
182.96 MPLN+4.40%
175.25 MPLN+2.22%
171.45 MPLN-0.51%
172.32 MPLN+5.00%
164.11 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neuca Stock analysis

What does Neuca do? NEUCA SA generates revenue through the wholesale distribution of pharmaceutical products to pharmacies, leveraging its extensive network in the health market. The company also produces and sells its own branded drugs, supplements, and cosmetics, while offering clinical trials, telemedicine services, and IT solutions tailored for healthcare providers. Its e-commerce platform further supports the healthcare industry by enabling digital transactions for medical products and services. The primary buyers include pharmacies, healthcare institutions, and consumers seeking health-related products through online channels. NEUCA SA's business model integrates multiple revenue streams within the health sector, with a focus on both physical and digital distribution. The firm's own-brand products, such as pharmaceuticals and cosmetics, are sold directly to end-users and retail partners, while its IT solutions and telemedicine services target healthcare organizations. Clinical trials represent another key segment, attracting partnerships with research institutions and pharmaceutical firms. The company's operational scope spans from production to distribution, ensuring a comprehensive approach to healthcare market needs. The company's revenue is driven by its diversified portfolio, including drug distribution, branded product sales, and specialized services like telemedicine and clinical trials. Pharmacies remain the core customer segment for its wholesale operations, while e-commerce and IT solutions cater to a broader audience of healthcare providers and consumers. NEUCA SA's strategic positioning in the health market allows it to capitalize on multiple growth areas without relying on a single revenue source. Neuca is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neuca stock

Total Operating Expenses of Neuca is 459.99 M PLN in 2025.

Total Operating Expenses of Neuca changed from 387.40 M PLN to 459.99 M PLN, representing a 18.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Neuca since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Neuca historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Neuca

All Key Metrics — Neuca